2021-2027 Global and Regional Antidiabetic Drug Industry Status and Prospects Professional Market Research Report Standard Version
Date: Aug-2021 | Id: MACRC-71944 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Antidiabetic Drug market was valued at 4376.24 Million USD in 2020 and will grow with a CAGR of 10% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of Biguanides, Sulphonylureas diabetes mellitus is a combination of peripheral insulin resistance and ß cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic DrugThe global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period. By Market Verdors: Sanofi-Aventis Eli Lilly Oramed Takeda Boehringer Ingelheim Novo Nordisk Halozyme Therapeutics Bristol-Myers Squibb Pfizer Tonghua Dongbao Biocon Wockhardt By Types: Alpha-Glucosidase Inhibitors Biguanides, Sulphonylureas Glp-1 Agonist Meglitinides Dpp-4 Inhibitors Sglt-2 Thiazolodinediones By Applications: Type I Diabetes Type II Diabetes Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Antidiabetic Drug Market Size Analysis from 2022 to 2027 1.5.1 Global Antidiabetic Drug Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Antidiabetic Drug Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Antidiabetic Drug Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Antidiabetic Drug Industry Impact Chapter 2 Global Antidiabetic Drug Competition by Types, Applications, and Top Regions and Countries 2.1 Global Antidiabetic Drug (Volume and Value) by Type 2.1.1 Global Antidiabetic Drug Consumption and Market Share by Type (2016-2021) 2.1.2 Global Antidiabetic Drug Revenue and Market Share by Type (2016-2021) 2.2 Global Antidiabetic Drug (Volume and Value) by Application 2.2.1 Global Antidiabetic Drug Consumption and Market Share by Application (2016-2021) 2.2.2 Global Antidiabetic Drug Revenue and Market Share by Application (2016-2021) 2.3 Global Antidiabetic Drug (Volume and Value) by Regions 2.3.1 Global Antidiabetic Drug Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Antidiabetic Drug Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Antidiabetic Drug Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Antidiabetic Drug Consumption by Regions (2016-2021) 4.2 North America Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) 4.10 South America Antidiabetic Drug Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Antidiabetic Drug Market Analysis 5.1 North America Antidiabetic Drug Consumption and Value Analysis 5.1.1 North America Antidiabetic Drug Market Under COVID-19 5.2 North America Antidiabetic Drug Consumption Volume by Types 5.3 North America Antidiabetic Drug Consumption Structure by Application 5.4 North America Antidiabetic Drug Consumption by Top Countries 5.4.1 United States Antidiabetic Drug Consumption Volume from 2016 to 2021 5.4.2 Canada Antidiabetic Drug Consumption Volume from 2016 to 2021 5.4.3 Mexico Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 6 East Asia Antidiabetic Drug Market Analysis 6.1 East Asia Antidiabetic Drug Consumption and Value Analysis 6.1.1 East Asia Antidiabetic Drug Market Under COVID-19 6.2 East Asia Antidiabetic Drug Consumption Volume by Types 6.3 East Asia Antidiabetic Drug Consumption Structure by Application 6.4 East Asia Antidiabetic Drug Consumption by Top Countries 6.4.1 China Antidiabetic Drug Consumption Volume from 2016 to 2021 6.4.2 Japan Antidiabetic Drug Consumption Volume from 2016 to 2021 6.4.3 South Korea Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 7 Europe Antidiabetic Drug Market Analysis 7.1 Europe Antidiabetic Drug Consumption and Value Analysis 7.1.1 Europe Antidiabetic Drug Market Under COVID-19 7.2 Europe Antidiabetic Drug Consumption Volume by Types 7.3 Europe Antidiabetic Drug Consumption Structure by Application 7.4 Europe Antidiabetic Drug Consumption by Top Countries 7.4.1 Germany Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.2 UK Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.3 France Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.4 Italy Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.5 Russia Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.6 Spain Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.7 Netherlands Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.8 Switzerland Antidiabetic Drug Consumption Volume from 2016 to 2021 7.4.9 Poland Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 8 South Asia Antidiabetic Drug Market Analysis 8.1 South Asia Antidiabetic Drug Consumption and Value Analysis 8.1.1 South Asia Antidiabetic Drug Market Under COVID-19 8.2 South Asia Antidiabetic Drug Consumption Volume by Types 8.3 South Asia Antidiabetic Drug Consumption Structure by Application 8.4 South Asia Antidiabetic Drug Consumption by Top Countries 8.4.1 India Antidiabetic Drug Consumption Volume from 2016 to 2021 8.4.2 Pakistan Antidiabetic Drug Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Antidiabetic Drug Market Analysis 9.1 Southeast Asia Antidiabetic Drug Consumption and Value Analysis 9.1.1 Southeast Asia Antidiabetic Drug Market Under COVID-19 9.2 Southeast Asia Antidiabetic Drug Consumption Volume by Types 9.3 Southeast Asia Antidiabetic Drug Consumption Structure by Application 9.4 Southeast Asia Antidiabetic Drug Consumption by Top Countries 9.4.1 Indonesia Antidiabetic Drug Consumption Volume from 2016 to 2021 9.4.2 Thailand Antidiabetic Drug Consumption Volume from 2016 to 2021 9.4.3 Singapore Antidiabetic Drug Consumption Volume from 2016 to 2021 9.4.4 Malaysia Antidiabetic Drug Consumption Volume from 2016 to 2021 9.4.5 Philippines Antidiabetic Drug Consumption Volume from 2016 to 2021 9.4.6 Vietnam Antidiabetic Drug Consumption Volume from 2016 to 2021 9.4.7 Myanmar Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 10 Middle East Antidiabetic Drug Market Analysis 10.1 Middle East Antidiabetic Drug Consumption and Value Analysis 10.1.1 Middle East Antidiabetic Drug Market Under COVID-19 10.2 Middle East Antidiabetic Drug Consumption Volume by Types 10.3 Middle East Antidiabetic Drug Consumption Structure by Application 10.4 Middle East Antidiabetic Drug Consumption by Top Countries 10.4.1 Turkey Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.3 Iran Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.5 Israel Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.6 Iraq Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.7 Qatar Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.8 Kuwait Antidiabetic Drug Consumption Volume from 2016 to 2021 10.4.9 Oman Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 11 Africa Antidiabetic Drug Market Analysis 11.1 Africa Antidiabetic Drug Consumption and Value Analysis 11.1.1 Africa Antidiabetic Drug Market Under COVID-19 11.2 Africa Antidiabetic Drug Consumption Volume by Types 11.3 Africa Antidiabetic Drug Consumption Structure by Application 11.4 Africa Antidiabetic Drug Consumption by Top Countries 11.4.1 Nigeria Antidiabetic Drug Consumption Volume from 2016 to 2021 11.4.2 South Africa Antidiabetic Drug Consumption Volume from 2016 to 2021 11.4.3 Egypt Antidiabetic Drug Consumption Volume from 2016 to 2021 11.4.4 Algeria Antidiabetic Drug Consumption Volume from 2016 to 2021 11.4.5 Morocco Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 12 Oceania Antidiabetic Drug Market Analysis 12.1 Oceania Antidiabetic Drug Consumption and Value Analysis 12.2 Oceania Antidiabetic Drug Consumption Volume by Types 12.3 Oceania Antidiabetic Drug Consumption Structure by Application 12.4 Oceania Antidiabetic Drug Consumption by Top Countries 12.4.1 Australia Antidiabetic Drug Consumption Volume from 2016 to 2021 12.4.2 New Zealand Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 13 South America Antidiabetic Drug Market Analysis 13.1 South America Antidiabetic Drug Consumption and Value Analysis 13.1.1 South America Antidiabetic Drug Market Under COVID-19 13.2 South America Antidiabetic Drug Consumption Volume by Types 13.3 South America Antidiabetic Drug Consumption Structure by Application 13.4 South America Antidiabetic Drug Consumption Volume by Major Countries 13.4.1 Brazil Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.2 Argentina Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.3 Columbia Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.4 Chile Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.5 Venezuela Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.6 Peru Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Antidiabetic Drug Consumption Volume from 2016 to 2021 13.4.8 Ecuador Antidiabetic Drug Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Antidiabetic Drug Business 14.1 Sanofi-Aventis 14.1.1 Sanofi-Aventis Company Profile 14.1.2 Sanofi-Aventis Antidiabetic Drug Product Specification 14.1.3 Sanofi-Aventis Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Eli Lilly 14.2.1 Eli Lilly Company Profile 14.2.2 Eli Lilly Antidiabetic Drug Product Specification 14.2.3 Eli Lilly Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Oramed 14.3.1 Oramed Company Profile 14.3.2 Oramed Antidiabetic Drug Product Specification 14.3.3 Oramed Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Takeda 14.4.1 Takeda Company Profile 14.4.2 Takeda Antidiabetic Drug Product Specification 14.4.3 Takeda Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Boehringer Ingelheim 14.5.1 Boehringer Ingelheim Company Profile 14.5.2 Boehringer Ingelheim Antidiabetic Drug Product Specification 14.5.3 Boehringer Ingelheim Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Novo Nordisk 14.6.1 Novo Nordisk Company Profile 14.6.2 Novo Nordisk Antidiabetic Drug Product Specification 14.6.3 Novo Nordisk Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 Halozyme Therapeutics 14.7.1 Halozyme Therapeutics Company Profile 14.7.2 Halozyme Therapeutics Antidiabetic Drug Product Specification 14.7.3 Halozyme Therapeutics Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Bristol-Myers Squibb 14.8.1 Bristol-Myers Squibb Company Profile 14.8.2 Bristol-Myers Squibb Antidiabetic Drug Product Specification 14.8.3 Bristol-Myers Squibb Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Pfizer 14.9.1 Pfizer Company Profile 14.9.2 Pfizer Antidiabetic Drug Product Specification 14.9.3 Pfizer Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Tonghua Dongbao 14.10.1 Tonghua Dongbao Company Profile 14.10.2 Tonghua Dongbao Antidiabetic Drug Product Specification 14.10.3 Tonghua Dongbao Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.11 Biocon 14.11.1 Biocon Company Profile 14.11.2 Biocon Antidiabetic Drug Product Specification 14.11.3 Biocon Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.12 Wockhardt 14.12.1 Wockhardt Company Profile 14.12.2 Wockhardt Antidiabetic Drug Product Specification 14.12.3 Wockhardt Antidiabetic Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Antidiabetic Drug Market Forecast (2022-2027) 15.1 Global Antidiabetic Drug Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Antidiabetic Drug Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Antidiabetic Drug Value and Growth Rate Forecast (2022-2027) 15.2 Global Antidiabetic Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Antidiabetic Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Antidiabetic Drug Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Antidiabetic Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Antidiabetic Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Antidiabetic Drug Consumption Forecast by Type (2022-2027) 15.3.2 Global Antidiabetic Drug Revenue Forecast by Type (2022-2027) 15.3.3 Global Antidiabetic Drug Price Forecast by Type (2022-2027) 15.4 Global Antidiabetic Drug Consumption Volume Forecast by Application (2022-2027) 15.5 Antidiabetic Drug Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000